Table 4.

Skin autofluorescence readings (AU) in potentially significant subgroups

YesNo
Male2.8 ± 0.7a2.7 ± 0.6
Diabetes3.0 ± 0.7a2.7 ± 0.6
No formal qualifications2.8 ± 0.6a2.6 ± 0.6
Previous cardiovascular event2.9 ± 0.7a2.7 ± 0.6
CKD stage 3B3.0 ± 0.6a2.7 ± 0.6
Anemia3.0 ± 0.7a2.7 ± 0.6
  • eGFR 45 to 59.9 ml/min per 1.73 m2; CKD Stage 3B, chronic kidney disease stage 3B.

  • a P < 0.001 versus comparator group.